Male Infertility Medical Services in China

Male infertility, a urological and reproductive endocrinology condition, refers to the inability of a male partner to achieve pregnancy with a female partner after 12 months of regular, unprotected intercourse. Etiologies are diverse and may include spermatogenic disorders (e.g., oligozoospermia, asthenozoospermia, teratozoospermiaive azoospermia), obstructive pathologies (e.g., congenital bilateral absence of the vas deferens or post-infectious epididymal obstruction), hormonal imbalances (hypogonadotropic hypogonadism, hyperprolactinemia), genetic factors (Klinefelter syndrome, Y-chromosome microdeletions), varicocele, or lifestyle-related contributors such as obesity, smoking, or environmental toxin exposure. Diagnosis involves comprehensive evaluation: semen analysis per WHO 6th edition criteria, hormonal profiling (FSH, LH, testosterone, prolactin, inhibin B), scrotal ultrasound, genetic testing where indicated, and, in select cases, testicular biopsy or micro-TESE. Management ranges from pharmacotherapy and surgical correction (e.g., varicocelectomy, vasoepididymostomy) to assisted reproductive technologies—including IUI, IVF, and ICSI—often guided by multidisciplinary fertility teams.

China offers distinct advantages for international patients seeking male infertility care. The country hosts nationally accredited Reproductive Medicine Centers with board-certified andrologists and reproductive endocrinologists trained in both Western and integrative protocols. Advanced diagnostics—including high-magnification sperm morphology analysis (MSOME), DNA fragmentation testing (SCD, TUNEL), and next-generation sequencing for genetic screening—are widely available. Success rates for micro-TESE combined with ICSI in non-obstructive azoospermia exceed 50% in leading centers, supported by robust clinical outcome data published in peer-reviewed journals. Treatment costs remain significantly lower than in the US, UK, or Germany—typically 40–60% less for comparable ART cycles—without compromising evidence-based standards or regulatory oversight (NMPA-approved devices, ISO-certified labs). As a dedicated medical tourism agency, we facilitate seamless access to these services: vetting JCI-accredited hospitals, coordinating consultations and procedures, providing transparent, all-inclusive pricing packages, arranging visa support and accommodation, and offering multilingual case management from initial inquiry through post-treatment follow-up.

Treatment Options & Itemized Cost Breakdown: Male Infertility (Andrology Department)

Non-Surgical / Conservative / Medication Options

*Target criteria:* Hormonal imbalances (hypogonadotropic hypogonadism), mild oligozoicocele-related subfertility without surgical indication, idiopathic infertility with normal anatomy.

• •HCG/hMG or Clomiphene)

- Monthly injectables (hCG 1,000 IU + hMG 75 IU × 2/wk): $180–$240/month citrate (25 mg/day): $15–$25/month - Semen analysis (post-treatment, 3-month interval): $30–$40/test

• •Antioxidant & Adjunctive Supplements

- Mandatory pre-supplement semen analysis + sperm DNA fragmentation test: $110–$140

Surgical / Procedural Options

*Eligibility criteria:* Clinical varicocele (Grade II–III), obstructive azoospermia (e.g., post-vasectomy, CBAVD), testicular failure workup requiring biopsy.

• •Microsurgical Varicocelectomy (bilateral, inguinal approach)

- Surgery fee (including OR time, microscope use, anesthesia): $1,450–$1,950 - Post-op semen analysis at 3/6 months: $30–$40/test

• •Percutaneous Sperm Retrieval (TESA/PESA)

- Procedure (under local anesthesia, unilateral/bilateral): $480–$650

• •Micro-TESE (Microdissection Testicular Sperm Extraction)

- Procedure (3–4 hr OR, intraoperative microscopy, tissue processing): $2,100–$2,750

Special / Complex Condition Management

• •Genetic Causes (Klinefelter, Y-deletion, CFTR mutations)

- IVF-ICSI coordination (sperm retrieval + embryology support): $4,200–$5,600 (separate from ART center fees)

• •Post-Chemotherapy/Radiation Recovery

- Gonadotropin stimulation trial (if residual spermatogenesis): $180–$240/month × 6 months

Quick Selection Guide

• •<35 years, mild oligozoospermia, budget < $500: Start with hormonal therapy + antioxidants ($220–$350 initial month)
• •35–42 years, palpable varicocele, moderate teratozoospermia: Microsurgical varicocelectomy ($1,580–$2,110 total first-year cost)
• •Azoospermia, normal FSH/testosterone: Proceed directly to micro-TESE ($2,420–$3,160, includes genetics & procedure)
• •Comorbid obesity/diabetes: Prioritize metabolic optimization (lifestyle + metformin) + semen analysis every 6 months ($75–$110/year) before escalating intervention
• •Severe male factor + female partner >38 years: Expedite micro-TESE + IVF-ICSI referral ($6,500–$8,750 total andrology + embryology coordination)